Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
SUVEN

Suven Life Sciences Share Price

 

 

Suven Life Sciences live price: ₹202.05. It opened at ₹208 vs previous close ₹208; intraday high/low: ₹209/₹200. The 50 & 200 DMA stand at ₹166.61/₹172.07.

Suven Life Sciences Performance

  • Today's Low
  • ₹200
  • Today's High
  • ₹209
  • 52 Week Low
  • ₹120
  • 52 Week High
  • ₹300
  • Open Price₹208
  • Previous Close₹208
  • Volume284,101
  • 50 DMA₹166.61
  • 100 DMA₹166.59
  • 200 DMA₹172.07

Suven Life Sciences Chart

Investment Returns

  • Over 1 Month + 56.46%
  • Over 3 Month + 50.7%
  • Over 6 Month + 1.2%
  • Over 1 Year + 43.09%

Smart Investing Starts Here Start SIP with Suven Life Sciences for Steady Growth!

Invest Now

Suven Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -19.4
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 5,329
  • P/B Ratio
  • 29.1
  • Average True Range
  • 10.59
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 14.38
  • RSI
  • 69.59
  • MFI
  • 87.93

Suven Life Sciences Financials

Suven Life Sciences Technicals

EMA & SMA

Current Price
₹202.05
-5.61 (-2.7%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹183.39
  • 50 Day
  • ₹166.61
  • 100 Day
  • ₹166.59
  • 200 Day
  • ₹172.07

Resistance and Support

203.8 Pivot Speed
  • R3 216.20
  • R2 212.65
  • R1 207.35
  • S1 198.50
  • S2 194.95
  • S3 189.65

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Suven Life Sciences Ltd. is a leading pharmaceutical company in India, specializing in the development of novel drug candidates and contract research services. The company focuses on CNS (central nervous system) disorders, providing innovative solutions for the global healthcare market.

Suven Life Sciences has an operating revenue of Rs. 7.06 Cr. on a trailing 12-month basis. An annual revenue de-growth of -47% needs improvement, Pre-tax margin of -2415% needs improvement, ROE of -146% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 32% and 8% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Suven Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-29 Quarterly Results
2025-11-11 Quarterly Results
2025-08-13 Quarterly Results
2025-05-13 Audited Results & Preferential issue
2025-01-24 Quarterly Results

Suven Life Sciences F&O

Suven Life Sciences Shareholding Pattern

70.15%
1.79%
0.91%
0%
19.45%
7.7%

Suven Life Sciences FAQs

Suven Life Sciences share price is ₹202 As on 26 April, 2026 | 03:05

The Market Cap of Suven Life Sciences is ₹5328.5 Cr As on 26 April, 2026 | 03:05

The P/E ratio of Suven Life Sciences is -19.4 As on 26 April, 2026 | 03:05

The PB ratio of Suven Life Sciences is 29.1 As on 26 April, 2026 | 03:05

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23